BioInformant Worldwide, L.L.C.

BioInformant Worldwide, LLC, is a U.S. based research firm that specializes in market intelligence for the stem cell industry. We are the only company that has specifically served the stem cell sector since it emerged, and our singular focus allows our team allows us to produce data that enables you to better understand your markets, competitors, and customers.

To date, BioInformant has been featured on prominent news outlets that include Nature Biotechnology, the Wall Street Journal, CBS News, Yahoo Finance, Medical Ethics, MarketWatch, the Center for BioNetworking, and many more.


In addition, our management team comes from a BioInformatics background – the science of collecting and analyzing complex genetic codes – and we are trained in applying these advanced data analysis techniques to the field of market research.

As a stem cell research firm, we use technology to track and identify profitable opportunities within the stem cell sector and provide this data to clients pursuing aggressive growth. Serving Fortune 500 leaders that include GE Healthcare, Pfizer, Goldman Sachs, Beckton Dickinson, Thermo Fisher Scientific, and many more, BioInformant is your trusted source of stem cell industry data.

BioInformant Worldwide, L.L.C.
 

List of reports from BioInformant Worldwide, L.L.C.

Coronavirus (COVID-19)—Global Market Conditions, Vaccines, Trials & Potential Treatments
3/1/2020 | published by: BioInformant Worldwide, L.L.C.
... the disease is also known as severe acute respiratory syndrome coronavirus 2 and abbreviated as SARS-CoV-2. The eruption started in China on December 29, 2019 and by March 2020 it was reported that it had ...  |  read more...
USD 497
Stem Cell Research Products – Opportunities, Tools, & Technologies (2020)
1/1/2020 | published by: BioInformant Worldwide, L.L.C.
... Embryonic stem cells, derived from blastocysts Perinatal stem cells, obtained during the period immediately before and after birth Adult stem cells, found in adult tissues Induced pluripotent stem cells, produced by genetically reprogramming adults cells ...  |  read more...
USD 3,895
Global CAR-T Cell Therapy Market – Market Size, Forecasts, Trials & Trends
12/1/2019 | published by: BioInformant Worldwide, L.L.C.
... since the introduction of chemotherapy. CAR-T is a type of immunotherapy where doctors collect immune cells from a patient, modify them in a laboratory, and provide them the power to easily recognize and kill cancer ...  |  read more...
USD 3,795
Global Market for Gene Therapy 2019 – Product Pipeline, Market Size, & Forecasts
8/1/2019 | published by: BioInformant Worldwide, L.L.C.
... faulty or missing genes in order to treat genetic diseases. This report reviews key developments from across the gene therapy sector, evaluating the industry’s commercial successes and failures, regulatory issues across key global markets, manufacturing ...  |  read more...
USD 3,995
Mesenchymal Stem Cells - Advances & Applications, 2019
7/1/2019 | published by: BioInformant Worldwide, L.L.C.
... cell types. In addition to secreting factors that can stimulate tissue repair, MSCs can substantially alter their microenvironment, exerting effects that are both anti-inflammatory and anti-fibrotic. MSCs are advantageous over other stem cells types for ...  |  read more...
USD 3,995
Global Market for Regenerative Medicine 2019
7/1/2019 | published by: BioInformant Worldwide, L.L.C.
... trials, accelerated pathways for product approvals, new technologies to support cell and gene therapy manufacturing, and the potential for cell therapies to revolutionize healthcare. There are now accelerated pathways for advanced therapy medicinal products (ATMPs) ...  |  read more...
USD 3,995
Global Market for Cell Therapy & Tissue Engineering 2019
5/1/2019 | published by: BioInformant Worldwide, L.L.C.
... and tissue engineering (TE), with a focus on competitive dynamics and commercial successes and failures. Cell therapy is the utilization of living cells for the treatment or potential cure of human disease or injury. Tissue ...  |  read more...
USD 3,995
Strategic Development of Neural Stem and Progenitor Cell Products
3/1/2019 | published by: BioInformant Worldwide, L.L.C.
... brain. Neural stem cells (NSCs) are the self-renewing, multipotent cells that differentiate into the main phenotypes of the nervous system. These cell types include neurons, astrocytes, and oligodendrocytes. Neural progenitor cells (NPCs) are the progeny ...  |  read more...
USD 3,795
Global CAR-T Cell Therapy Market – Market Size, Forecasts, Trials & Trends
2/1/2019 | published by: BioInformant Worldwide, L.L.C.
... acute lymphoblastic leukemia (ALL). Soon after, on October 18, 2017, FDA granted approval for Axicabtagene ciloleucel (Yescarta) for treating patients with relapsed/refractory diffuse large B-cell lymphoma (r/rDLBCL) and other rare large B-cell lymphomas. Other notable ...  |  read more...
USD 3,795
Global Induced Pluripotent Stem Cell (iPS Cell) Industry Report 2018-19
10/15/2018 | published by: BioInformant Worldwide, L.L.C.
... stem cells through the manipulation of gene expression, as well as other methods. Research and experimentation using mouse cells by Shinya Yamanaka’s lab at Kyoto University in Japan was the first instance in which there ...  |  read more...
USD 3,795
Global Cord Blood Banking Industry Report 2018
4/1/2018 | published by: BioInformant Worldwide, L.L.C.
... has created both serious threats and novel opportunities for the industry. Serious threats to the industry include low rates of utilization for stored cord blood, expensive cord blood transplantation procedures, difficulty educating obstetricians about cellular ...  |  read more...
USD 3,795
Mesenchymal Stem Cells - Advances & Applications (2018)
2/1/2018 | published by: BioInformant Worldwide, L.L.C.
... other cell types. In addition to secreting factors that can stimulate tissue repair, MSCs can substantially alter their microenvironment, exerting effects that are both anti-inflammatory and anti-fibrotic. MSCs are advantageous over other stem cells types ...  |  read more...
USD 3,795
Strategic Development of Neural Stem & Progenitor Cell Products (2018)
1/1/2018 | published by: BioInformant Worldwide, L.L.C.
... the growing brain. Neural stem cells (NSCs) are the self-renewing, multipotent cells that differentiate into the main phenotypes of the nervous system. These cell types include neurons, astrocytes, and oligodendrocytes. Neural progenitor cells (NPCs) are ...  |  read more...
USD 2,995
The Market for Stem Cell Exosomes
12/1/2017 | published by: BioInformant Worldwide, L.L.C.
... cells to patients. Although exosomes were discovered more than 30 years ago, it was not until recently that the scientific community began to give credit to exosomes for a range of promising traits. Ten years ...  |  read more...
USD 2,795
Market Size Determination for the Cell Therapy CDMO Market
10/1/2017 | published by: BioInformant Worldwide, L.L.C.
... such as cell therapy contract and development manufacturing organizations (CDMOs). Benefits of partnering with a cell therapy CDMO include scalability, speed to market, access to technical expertise without overhead costs, and cost efficiencies. With more ...  |  read more...
USD 297
Complete 2017-18 Global Cord Blood Banking Industry Report
10/1/2017 | published by: BioInformant Worldwide, L.L.C.
... opportunities for the industry. Serious threats to the industry include low rates of utilization for stored cord blood, expensive cord blood transplantation procedures, difficulty educating obstetricians about cellular therapies, and an increasing trend toward industry ...  |  read more...
USD 3,795
The Market For Cell Therapy Manufacturing - Strategies for Pricing, Cost Control, Reimbursement, and Distribution
7/1/2017 | published by: BioInformant Worldwide, L.L.C.
... cell therapy products has introduced manufacturing complexity and regulatory concerns, as well as scale-up complexities that are not present within traditional pharmaceutical manufacturing. Furthermore, much of cell therapy manufacturing now involves patient-specific cell therapies, where ...  |  read more...
USD 2,495
Defining the Future of the Stem Cell Industry - Exclusive Interviews with Stem Cell Industry Executives
7/1/2017 | published by: BioInformant Worldwide, L.L.C.
... ability to divide and replicate repeatedly, as well as an “unspecialized” nature that allows them to differentiate into a wide variety of specialized cell types. In a developing embryo, stem cells can differentiate into all ...  |  read more...
USD 1,795
Stem Cell Research Products - Opportunities, Tools, & Technologies
2/1/2016 | published by: BioInformant Worldwide, L.L.C.
... identify new product development opportunities before the competition. Use the “Survey of Stem Cell Scientists” to understand technical requirements, unmet needs, and purchasing preferences of stem cell researchers worldwide. This report explores unique market opportunities ...  |  read more...
USD 3,795
Mesenchymal Stem Cells - Advances & Applications
11/1/2015 | published by: BioInformant Worldwide, L.L.C.
... Applications.” Published November 2015, it presents 250 pages of coverage for the rapidly-evolving mesenchymal stem cell (MSC) industry. Called the "most innovative market research firm in the world,” BioInformant tracks MSC industry metrics using continuously ...  |  read more...
USD 3,795
Complete 2015-16 Global Cord Blood Banking Industry Report
8/1/2015 | published by: BioInformant Worldwide, L.L.C.
... is designed to increase your efficiency and effectiveness in: 1.Commercializing cord blood products, technologies, and therapies 2.Making intelligent investment decisions 3.Launching high-demand products 4.Selling effectively to your client base 5.Increasing revenue 6.Taking market share from ...  |  read more...
USD 3,795
The Market for Stem Cell Biobanking and Storage - Size, Segments, and Trends.
6/1/2015 | published by: BioInformant Worldwide, L.L.C.
... the stem cell biobanking market. This global strategic report is produced for: Executives of Industrial-Scale Biobanks Management of Stem Cell Product Companies Management of Stem Cell Therapy Companies Biobanking Industry Investors It is designed to ...  |  read more...
USD 1,395
Complete 2015-16 Induced Pluripotent Stem Cell (iPSC) Industry Report
4/1/2015 | published by: BioInformant Worldwide, L.L.C.
... affecting industry patent rights, announcement of an iPSC cellular therapy clinic scheduled to open in 2019, and much more. Furthermore, iPSC patent dominance continues to cluster in specific geographic regions, while clinical trial and scientific ...  |  read more...
USD 3,795
Neural Stem & Progenitor Cell Products - Strategic Development
1/1/2012 | published by: BioInformant Worldwide, L.L.C.
... community uses the terms "neuronal" and "neural" interchangeably. The complexity of this issue is explored from a marketing perspective within this report. Over the past few years, neuronal stem and progenitor cells have become of ...  |  read more...
USD 3,495
 
US: 800.298.5699
Int'l: +1.240.747.3093
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!